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Abstract
Background The introduction of complete mesocolic excision (CME) for right colon cancer has raised an important dis-
cussion in relation to the extent of colic and mesenteric resection, and the impact this may have on lymph node yield. As 
uncertainty remains regarding the usefulness of and indications for right hemicolectomy with CME and the benefits of CME 
compared with a traditional approach, the purpose of this meta-analysis is to compare the two procedures in terms of safety, 
lymph node yield and oncological outcome.
Methods We performed a systematic review of the literature from 2009 up to March 15th, 2020 according to the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Two hundred eighty-one publications 
were evaluated, and 17 met the inclusion criteria and were included. Primary endpoints analysed were anastomotic leak rate, 
blood loss, number of harvested lymph nodes, 3- and 5-year oncologic outcomes. Secondary outcomes were operating time, 
conversion, intraoperative complications, reoperation rate, overall and Clavien–Dindo grade 3–4 postoperative complications.
Results In terms of safety, right hemicolectomy with CME is not inferior to the standard procedure when comparing rates of 
anastomotic leak (RR 0.82, 95% CI 0.38–1.79), blood loss (MD −32.48, 95% CI −98.54 to −33.58), overall postoperative 
complications (RR 0.82, 95% CI 0.67–1.00), Clavien–Dindo grade III–IV postoperative complications (RR 1.36, 95% CI 
0.82–2.28) and reoperation rate (RR 0.65, 95% CI 0.26–1.75). Traditional surgery is associated with a shorter operating time 
(MD 16.43, 95% CI 4.27–28.60) and lower conversion from laparoscopic to open approach (RR 1.72, 95% CI 1.00–2.96). 
In terms of oncologic outcomes, right hemicolectomy with CME leads to a higher lymph node yield than traditional surgery 
(MD 7.05, 95% CI 4.06–10.04). Results of statistical analysis comparing 3-year overall survival and 5-year disease-free 
survival were better in the CME group, RR 0.42, 95% CI 0.27–0.66 and RR 0.36, 95% CI 0.17–0.56, respectively.
Conclusions Right hemicolectomy with CME is not inferior to traditional surgery in terms of safety and has a greater lymph 
node yield when compared with traditional surgery. Moreover, right-sided CME is associated with better overall and disease-
free survival.
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Introduction
Tumors of the colon and rectum are the second most com-
mon tumor in women and the third in men [1]. Cancers 
located in the right colon, left colon and rectum appear 
to be different entities, and evolve differently. Surgery 
remains the mainstay of treatment when potential for cure 
is the aim. While surgical techniques for the rectum [2] 
have now been largely standardized and can be performed 
by different modes of access, there is ongoing debate about 
the extent of colic and mesenteric resection in surgery 
on the right colon and radicality of lymph node exci-
sion. Building on the concept of total mesorectal excision 
(TME), a new surgical era has opened for the right colon.
Complete mesocolic excision (CME) for the right colon 
was first described in 2009 by the Erlangen group (Ger-
many) [3], and subsequently, a similar concept referred to 
as D3 lymphadenectomy was reported in Asia. These ideas 
of an extended resection with potential increased oncologi-
cal radicality became topics of great interest to surgeons 
worldwide [4]. It is a surgical procedure that involves the 
complete separation of the parietal and visceral embryo-
logical planes, extending the resection to include the pan-
creatic lymph node stations and in some cases up to the 
greater curvature of the stomach [3]. This is associated 
with ligation at the origin of the appropriate colic vessels 
(known as central vascular ligation [CVL]), to widen the 
lymphatic resection and extension of the primary intestinal 
resection proportionate to the staging of the tumour.
There is still uncertainty about the indications for CME 
and the advantages of the technique compared to tradi-
tional right hemicolectomy [6] and CME is being evalu-
ated in numerous prospective studies. The purpose of this 
review and meta-analysis was to analyze the available data 
on right hemicolectomy with CME vs. traditional right 
hemicolectomy in terms of safety, feasibility and onco-
logical outcomes, and attempt to define the role of this 
controversial surgical procedure.
Materials and methods
We performed a systematic review of the literature from 
inception up to March 15th, 2020 according to the Pre-
ferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines [4]. Randomised con-
trolled trials (RCTs) and non-randomised controlled trials, 
which compared CME vs non-CME right hemicolectomy 
for colon cancer were considered for inclusion regardless 
of the surgical approach or the outcomes reported; if we 
had found both types of studies (RCTs and non-RCTs), we 
would have had to perform two separate meta-analyses and 
not a single meta-analysis.
All non-comparative studies were excluded. In the case 
of patients overlapping between two or more studies, only 
the most recent study was considered.
The comprehensive search of  the literature was per-
formed by analysing the relevant databases: Medline/Pub-
Med, Scopus, Web of Science, CNKI (中国知网) (China 
National Knowledge Infrastructure) Wanfang Data (万方) 
and other sources (Google Scholar) for articles reporting 
data on CME vs non-CME right hemicolectomy, without any 
language restrictions. The references of all included stud-
ies were screened to identify any study missed during the 
initial search.
The following search statement was used in Medline/
PubMed:
• cme[All Fields] AND right[All Fields] AND 
("colectomy"[MeSH Terms] OR "colectomy"[All 
Fields])
• complete[All Fields] AND mesocolic[All Fields] 
AND excision[All Fields] AND right[All Fields] AND 
("colectomy"[MeSH Terms] OR "colectomy"[All 
Fields])
• cme[All Fields] AND right[All Fields] AND 
("colectomy"[MeSH Terms] OR "colectomy"[All Fields] 
OR "hemicolectomy"[All Fields])
• complete[All Fields] AND mesocolic[All Fields] 
AND excision[All Fields] AND right[All Fields] AND 
("colectomy"[MeSH Terms] OR "colectomy"[All Fields] 
OR "hemicolectomy"[All Fields])
In the other bibliographic databases (WOS, Scopus, 
CNKI and Wanfang Data), the search was performed by 
entering the association of the following keywords:
• cme AND right AND colectomy
• cme right hemicolectomy
• complete AND mesocolic AND excision AND right 
AND colectomy
• complete AND mesocolic AND excision AND right 
AND hemicolectomy
Successively, another search was performed through the 
reference lists of the selected articles and relevant grey lit-
erature through Google Scholar. The studies of each data-
base were included in the bibliographic software package 
and the duplicate records were excluded. Furthermore, 
ClinicalTrials.gov was searched to collect the registered 
ongoing clinical trials. Two authors (RC, AG) individually 
evaluated the titles and abstracts of all studies. The full 
text of studies that could potentially fulfil the inclusion 
criteria was obtained. The same two authors independently 
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assessed these full texts to determine whether they met the 
inclusion criteria for this review.
Successively, the same two authors (RC, AG) individu-
ally extracted data from the studies. The information col-
lected from each study was as follows: year of publica-
tion, study design, inclusion criteria, exclusion criteria, 
and outcomes.
The primary outcomes were the anastomotic leak rate, 
the estimated blood loss, the overall number of harvested 
lymph nodes and 3-year to 5-year oncologic outcomes.. The 
secondary outcomes were the operative time, the conversion 
from laparoscopy to open right hemicolectomy, the intraop-
erative complications (e.g. vascular injuries, iatrogenic small 
bowel perforation), the overall postoperative complications, 
the Clavien–Dindo grade III–IV [5] postoperative compli-
cations and the reoperation rate. Robotic, laparoscopic and 
open cases were included in the analysis.
Statistical analysis
We calculated risk ratios (RR) for dichotomous variables 
and weighted mean differences (WMD) for continuous vari-
ables. Intention-to-treat analysis was performed.
The Mantel–Haenszel method was used for the meta-anal-
ysis. All results were displayed in a forest plot graph. The 
Q test was used to analyze the heterogeneity. An I2 statistic 
value ≥ 75% indicates a considerable level of heterogeneity. 
The data analysis was performed using the meta-analysis 
software Review Manager (RevMan) v 5.3.5 (Copenhagen: 
The Nordic Cochrane Centre, The Cochrane Collaboration, 
2018)[6].
The Risk of Bias In Non-randomized Studies of Interven-
tions (ROBINS-I) assessment tool was used to evaluate the 
methodological quality of the included studies [7], graphic 
visualization of the results was obtained with the aid of the 
ROBINS online tool [8]. All studies begin with the assump-
tion of a low level of risk of bias and were then downgraded 
by one or two ROBINS-I levels based on the applicable 
domains in the ROBINS-I tool.
Among all primary outcomes, subgroup analysis for dif-
ferent populations was performed between Asia and Europe.
We assessed the overall quality of the evidence for 
each outcome according to the Grading of Recommenda-
tions Assessment, Development and Evaluation (GRADE) 
approach [9]. We initially downgraded studies up to two 
levels in the GRADE system based upon the degree of 
risk of bias assessed using the ROBINS-I tool. We then 
downgraded the certainty of evidence further based on the 
domains specified in the GRADE system.
The protocol for this systematic review and meta-
analysis was submitted and accepted from PROSPERO: 
CRD42020166049 (http:// www. crd. york. ac. uk/ prosp ero).
Results
We retrieved 1194 records with our search strategy 
(Fig. 1). Among these, 913 were excluded, because they 
were duplicated. Subsequently, 281 titles and abstracts 
were evaluated, with 235 abstracts excluded, because they 
did not meet the inclusion criteria. After the evaluation 
of 46 full texts, 23 articles were excluded [10–32] with 
five ongoing studies (Table 1). Eighteen non-randomised 
controlled trials were included in the qualitative analysis, 
and 1 study [33] was subsequently excluded from quanti-
tative synthesis, because the reported data were not ade-
quate. Therefore, 17 were included in the meta-analysis 
(Table 2) [34–50].  
Description of studies.
A detailed description of the 17 included studies, and 
patient characteristics is provided in Table 2: the research-
ers enrolled 2508 patients (1203 CME and 1305 non-CME). 
Ten studies were performed in Asia (1262 patients, 50.32%), 
with China the nation performing the highest number of 
studies (7 studies, 1026 patients; 40.90%). The other 7 stud-
ies were performed in Europe (1246 patients, 49.68%), with 
Italy, the European nation performing the highest number of 
studies (543 patients, 21.29%). One of these Italian studies 
was performed in collaboration with colleagues from Egypt 
[40]. The studies included were published between 2012 and 
2020; the patients were enrolled between 2001 and 2019. 
There were no significant differences in age, sex, body mass 
index, American Society of Anesthesiologists class or TNM 
stage between the CME and non-CME groups.
Assessment of risk of bias in included studies
The risk of bias in the included studies was independently 
assessed by two authors (RC, FB).
In the ROBINS-I tool, risk-of-bias judgments may be 
classified as low, moderate, serious or critical. Four out of 
17 studies were assessed as having low risk of overall bias, 
while 4 were determined as having moderate risk, and 9 
as having serious risk. The most common cause of serious 
risk of bias was confounding. Concerning the domain of 
selection bias regarding study participants, 15 studies were 
evaluated to be at low risk of bias. Regarding bias in clas-
sification of the interventions, four were deemed to have 
low risk of bias and the rest were deemed to have moderate 
bias. Bias due to deviations from intended interventions was 
low in all studies. The evaluation of missing data bias was 
deemed as low risk in three studies; the other studies were 
deemed to have moderate risk with the exception of one 
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study with serious risk. Regarding bias in selection of the 
measurement of the outcomes, the studies all had a low risk 
of bias. In terms of bias of reported results, four studies were 
at low risk or moderate risk; the rest of the studies were at 
high risk of bias (Fig. 2).
For each outcome, we initially downgraded the overall 
quality of evidence (GRADE) by up to two levels depending 
on the degree of the risk-of-bias judgments and downgraded 
the quality further based on the GRADE evaluation criteria, 
as shown in Fig. 3. Overall, the quality of evidence was very 
low because of serious concerns regarding inconsistency 
and imprecision. Furthermore, other significant causes of 
downgrading of evidence were inconsistency of the results 
for the wide variance of point estimates across studies and 
the imprecision for the wide confidence interval of these 
outcomes in the few studies included. This was prominent 
for the more short-term outcomes, except for lymph node 
harvest—the only outcome reported in all included studies. 
The studies that reported disease-free survival (DFS) and 
overall survival (OS) had evidence downgraded by one level 
because of their imprecision; they were underpowered due to 
the low number of patients included. The degree of publica-
tion bias was difficult to ascertain and quantify.
Primary outcomes: statistical analyses result for second-
ary outcomes are presented in Table 3.
Anastomotic leak
Eleven studies [34, 37, 39, 42, 44–46, 48–51] reported 
this outcome (1508 patients). No statistically significant 
Fig. 1  Prisma flowchart of 
literature search Records idenfied through 
database searching 























Addional records idenfied 
through other sources 
(n = 8)
Records aer duplicates removed 
(n = 281) 
Records screened 
(n = 281) 
Records excluded 
(n = 235) 
Full-text arcles assessed 
for eligibility 
(n = 46)
Full-text arcles excluded (n = 23)
 
Brunner 
2020 A review 
Rinne 2020 The study included pts underwent different type of colectomies 
Zenger 
2019 A review 
Bertelsen 
2019 
The study included pts underwent 
different type of colectomies 
Schulte 
2019 A technical note 
Yang 2017 A protocol 
Wang 2017 A systematic review  
Siani 2016 A review 
Giuvas 
2016 A systematic review  
Lu 2016 A protocol 
Thorsen 
2016 
The characteristic CME mesocolic 
plane of surgery was not well 
standardized 
Athanasiou 
2016 A systematic review  
Olofsson 
2016 
The characteristic CME mesocolic 
plane of surgery was not well 
standardized 
Feng 2016 The study included pts underwent left colonic resection 
Merkel 
2016 
The study included pts underwent 
different type of colectomies 
Bertelsen 
2016 
The study included pts underwent 
different type of colectomies 
Siani 2015 
A comparison between mesocolic 
and non-mesocolic planes during 
right laparoscopic CME 
Bertelsen 
2015 
The study included pts underwent 
different type of colectomies 
Storli 2014 The study included pts underwent different type of colctomies 
Kobayashi 
2014 
The study included pts underwent 
different type of colectomies 
Bertelsen 
2011 
The study included pts underwent 
different type of colectomies 
West 2010 The study included pts underwent different type of colectomies 
Tagliacozzo 
1999 
The characteristic CME mesocolic 
plane of surgery was not well 
standardized 
Studies included in 
qualitave synthesis 
(n = 18)
Studies included in 
quantave synthesis 
(meta-analysis) 
(n = 17) 
Studies ongoing 
(n = 5) (Tab 1) 
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difference was found in the incidence of anastomotic leak 
in the CME group (1.44%, 11/764) and in the non-CME 
group (2.28%, 17/744), (RR 0.82, 95% CI 0.38–1.79); the 
same result was reported in the analysis of open and laparo-
scopic groups. Heterogeneity was absent (I2 = 0%) (Fig. 4). 
The overall quality of evidence was deemed to be very low 
Table 1  Ongoing studies
RCT randomized controlled trial, RESECTAT CME or traditional surgery for right-sided colon cancer. Protocol of a registry-based multicenter 
prospective non-randomized trial, REK 2015/2396 open D3 right colectomy compared to laparoscopic CME right colectomy for right-sided 
colon cancer; an Open Randomized Controlled Study, COMET complete mesocolic excision vs. standard of care right hemicolectomy ran-
domised controlled Trial, RELARC radical extent of lymphadenectomy—D2 dissection versus complete mesocolic excision of LAparoscopic 
Right Colectomy for right-sided colon cancer, SLRC standardization of laparoscopic surgery for right hemi colon cancer, UK United Kingdom, 
CME complete mesocolic excision
Name of study Type of study Year of 
registra-
tion











RCT 2018 NCT0377659 Norway NR 218 Laparoscopic 
CME right 
colectomy
























SLRC RCT 2016 NCT02942238 China NR 582 Laparoscopic 
CME right 
colectomy
Open D3 right 
colectomy
Table 2  Inclusion criteria
RCT randomized controlled trial, R observational retrospective, P observational prospective, LA laparoscopic assisted, RA robotic assisted, OA 
open access
Author—year of publication Nation Type of study N. of patients 
included
Time of enrolment Type of access
Pedrazzani 2020 [43] Italy R 114 2014–2019 LA
Yozgatli 2019 [48] Turkey P 96 2015–2017 RA/LA
Ho 2019 [39] Singapore R 25 2012–2015 LA
Ouyang 2019 [42] China R 167 2008–2015 LA
Zurleni 2018 [50] Italy R 192 2007–2012 OA
Prevost 2018 [44] Switzerland R 155 2001–2015 LA/OA
An 2018 [34] South Korea R 115 2007–2011 LA
Bertelsen 2018 [35] Denmark R 465 2008–2014 LA/OA
Cao 2018 [36] China R 189 2006–2017 LA
Zhao 2017 [49] China R 47 2010–2015 LA/OA
Yang 2017 [23] China R 125 2012–2015 LA/OA
Lieto 2017 [40] Italy/Egypt R 134 2008–2016 OA
Procházka 2016 [45] Czech Republic P 83 2014–2015 OA
Qin 2016 [46] China R 336 2005–2014 OA
Liu 2015 [41] China R 70 2010–2014 LA
Galizia 2014 [37] Italy P 103 2008–2012 OA
Gao 2012 [38] China R 92 2008–2011 OA
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because of multiple risk-of-bias downgrades and inconsist-
ency of results.
Blood loss
Twelve studies [34, 36–38, 40–44, 46, 48, 49] reported this 
outcome (1618 patients: 877 laparoscopic vs 741 open). 
There was no difference in the estimated blood loss was 
no different in the CME group and the non-CME group 
(MD −32.48, 95% CI −98.54 to −33.58), and the hetero-
geneity was high (I2 = 100%). Subgroup analysis reported a 
significantly lower estimated blood loss in the laparoscopic 
CME group (MD −15.78, 95% CI −22.03 to −9.53; par-
ticipants = 655; studies = 5); the heterogeneity was very 
low (I2 = 5%) (Fig. 5). The overall quality of evidence was 
deemed to be very low because of multiple risk-of-bias 
downgrades and imprecision.
Overall number of harvested lymph nodes
Seventeen studies [34–50] reported this outcome (2508 
patients, 1203 CME vs 1305 non-CME). The overall num-
ber of harvested lymph nodes was significantly higher in 
the CME group (MD 7.05, 95% CI 4.06–10.04); this trend 
significantly favoring CME was reported in all the subgroup 
analyses. The heterogeneity was significantly high (I2 = 98%) 
and may be due to subgroup effects. Subgroup analyses of 
the different surgical modes of access reported a significantly 
higher number of harvested lymph nodes in the CME group, 
but the heterogeneity was very high in all the subgroups 
(Fig. 6). Another subgroup analysis of different populations 
reported that the overall number of harvested lymph nodes 
was statistically higher in the CME group in Asia (MD 
6.16, 95% CI 3.75–8.58; participants = 1262; studies = 10; 
I2 = 96%) and Europe (MD 7.95, 95% CI 3.13–12.77; par-
ticipants = 1246; studies = 7; I2 = 94%). Overall, the quality 
of evidence was deemed to be low because of multiple risk-
of-bias downgrades.
Three‑ and 5‑year oncologic outcomes
Few studies reported the oncological outcomes at 3 and 
5 years, but the data are not statistically comparable and 
are extremely heterogeneous between the included stud-
ies. However, all long-term oncological outcomes (local 
recurrence, systemic recurrence, overall survival [OS] and 
disease-free survival [DFS]) favored the CME vs non-CME 
groups (Table 4).
Regarding 3-year oncological outcomes, Ouyang et al. 
and Zurleni et al. [42, 50] reported only overall survival. 
This was higher for the CME group in the study of Ouyang 
(OS 93.5% in the CME group and 85% in the non-CME 
group) than in the study by Zurleni (OS 88% in the CME 
group and 71% in non-CME group). The OS was signifi-
cantly better in CME group than non-CME groups (RR 
0.42, 95% CI 0.27–0.66; p = 0.0002. participants = 359; 
studies = 2; I2 = 0%) (Fig. 7).
Regarding 5-year oncological outcomes, the studies by 
An et al., Lieto et al. and Qin et al. [34, 40, 46] reported 
only DFS. This was higher for the CME group in the study 
of An (DFS 94.12% in the CME group and 89.17% in the 
non-CME group) than in the studies by Lieto (DFS 89.2% 
in the CME group and 49.1% in the non-CME group) and 
Quin (DFS 89.8% in CME group and 82.2% in non-CME 
group). The DFS was significantly better in CME group than 
non-CME groups (RR 0.36, 95% CI 0.17–0.56; p 0.007. 
participants = 585; studies = 3; I2 = 61%). This heterogene-
ity is probably due to more favorable tumour stage in the 
study of An, which reported a higher rate of patients with 
TNM stage I (35 patients, 30.43%), compared with a lower 
rate (6.25%) of patients with stage I disease in the study by 
Quin. In addition, there was a higher rate of patients with 
TNM stage IV disease (9 patients, 6.71%) in the study of 
Lieto compared to those of An and Quin, neither of which 
included patients with stage IV disease (Fig. 8). For both 
3- and 5-year outcomes, the quality of evidence was deemed 
Fig. 2  The risk of bias according to ROBINS-I tool
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to be very low because of imprecision and multiple risk-of-
bias downgrades.
Secondary outcomes: statistical analyses result for sec-
ondary outcomes are presented in Table 5.
Operative time
Fourteen studies [34, 36–46, 48, 49] reported this outcome 
Right hemicolectomy with complete mesocolic excision compared to conventional right hemicolectomy 
Patient or population: patients with right colon cancer 
Intervention: Right hemicolectomy with complete mesocolic excision
Comparison: Conventional right hemicolectomy 
Outcomes No of 
Participants
(studies)
Study event rates (%) Relative effect
(95% CI)
Anticipated absolute effects Quality of the 
evidence
(GRADE)




11/764 (1.4%) 17/744 (2.3%) RR 0.82 
(0.38 to 1.79)
4 fewer per 1.000
(from 14 fewer to 
18 more)




877 741 - MD 32.48 lower
(98.54 lower to 33.58 higher)
⊕⊝⊝⊝
very low1,2,4
Overall number of harvested lymph nodes 2508
(17 studies)
1203 1305 - MD 7.05 higher
(4.06 higher to 10.04 higher)
⊕⊕⊝⊝
low1,2
OS  3 years 359
(2 studies)
25/204 (12.3%) 45/155 (29%) RR 0.42
(0.27 to 0.66)
168 fewer per 
1.000
(from 212 fewer to 
99 fewer)
290 per 1.000 ⊕⊝⊝⊝
very low1,2,5
DFS  3 years 585
(3 studies) 33/340 (9.7%) 56/245 (22.9%)
RR 0.36
(0.17 to 0.76)
146 fewer per 
1.000
(from 190 fewer to 
55 fewer)
229 per 1.000 ⊕⊝⊝⊝
very low1,2,5
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in 
the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk ratio; MD: Mean difference, CME: Complete mesocolic excision; OS:Overall survival; DFS:Disease-free survival
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect. 
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Quality of evidence was downgraded at least one level because of imitations in study design or execution (non-randomized trials) based on the ROBINS-I tool.
2 Quality of evidence was downgraded two level because of limitations in study design or execution based on the ROBINS-I tool. 
a Inconsistency of results (wide variance of point estimates across studies)
4 Imprecision of results (wide confidence interval)
5 Imprecision of results (underpowered size for number of low patients reported)
Fig. 3  GRADE Working Group grades of evidence
Table 3  Primary outcomes
RR (relative risk) < 1 favours CME; > 1 favours non-CME. MD (mean difference) < 0 favours CME; > 0 favours non-CME
CME complete mesocolic excision
Number of stud-










RR/MD 95% CI Hetero-
geneity 
 (I2)%
Anastomotic leak 11 1508 11/764 (1.44%) 17/744 (2.28%) 0.82 0.38–1.79 0
Blood loss 12 1618 877 741 -32.48 −98.54 to −33.58 100
Overall number of 
harvested lymph 
nodes
17 2508 1203 1305 7.05 4.06-10-04 98
3 year overall survival 2 359 204 155 0.34 0.20–0.59 0
5 year disease-free 
survival
3 585 340 245 0.36 0.17–0.76 61
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Fig. 4  Anastomotic leak
Fig. 5  Blood loss
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(1736 patients: 902 CME group vs 834 non-CME group). 
The authors do not report if the operative time is "calcu-
lated from skin incision to application of wound dressings", 
and for this reason it was judged an unclear risk of bias. 
The operative time (reported in minutes as mean difference, 
[MD]) was significantly higher in the CME group than in the 
non-CME group (MD 16.43, 95% CI 4.27–28.60); this trend 
was the same in all the subgroup analyses. The heterogeneity 
was high (I2 = 95%).
Conversion from laparoscopy to open right 
hemicolectomy
Four studies [34–36, 39] reported this outcome (682 
patients). The incidence of conversion to open from lapa-
roscopic surgery was statistically significantly higher in the 
CME group (8.49%, 18/212) compared with the non-CME 
group (7.6%, 35/460) (RR 1.72, 95% CI 1.00–2.96). There 
was no heterogeneity (I2 = 0%).
Intraoperative complications (vascular injuries 
or visceral perforation)
Three studies [43, 44, 48] reported this outcome (partici-
pants = 365). The incidence of intraoperative complications 
was the same in the CME group (10.67%, 19/178) and in the 
non-CME group (7.48%, 14/187), as the difference was not 
statistically significant (RR 1.14, 95% CI 0.60–2.15). There 
was no heterogeneity (I2 = 0%).
Reoperation rate
Four studies [36, 43, 48, 50] reported this outcome (591 
patients). The incidence of reoperation rate was no dif-
ferent in the two groups, as the difference was not statis-
tically significant (RR 0.65, 95% CI 0.26–1.75). There 
was no heterogeneity (I2 = 0%). The limitation of this 
analysis is the lack of data about the time interval that 
was involved.
Overall postoperative complications
Ten studies [36, 37, 39, 40, 42, 43, 46, 48–50] reported this 
outcome (1307 patients). The incidence of overall post-
operative complications was found to be the same in the 
CME group (17.94%, 141/786) and in the non-CME group 
(21.16%, 142/617), since the difference was not statistically 
significant (RR 0.82, 95% CI 0.67–1.00 I2 = 0%).
Fig. 6  Lymph node yield
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Clavien–Dindo grade III–IV postoperative 
complications
Three studies [35, 43, 48] reported this outcome (447 
patients). The incidence of postoperative complications was 
the same in the CME group (12.26%, 19/155) and the non-
CME group (11.92%, 43/338) (RR 1.36, 95% CI 0.82–2.28; 
I2 = 0%); these complications included anastomotic leaks 
and it was not possible to analyze these outcomes without 
including anastomotic leak.
Discussion
The oncological principles of colon and rectal cancer sur-
gery involve the removal of the tumour along with an ade-
quate amount of healthy bowel, blood vessels and drain-
ing lymph nodes. TME radically changed rectal cancer 
surgery, bringing important improvements in terms of 
reduction of local recurrence [52]. In 2009 with the intro-
duction of CME, Hohenberger[53] transferred the prin-
ciples of TME to right colon surgery by demonstrating 
that parietal and visceral peritoneum surrounds the right 
colon just as the mesorectum surrounds the rectum. As 
for TME, following the visceral and parietal peritoneum 
plane, resections can be obtained along the most effective 
surgical planes. CME mandates surgical dissection along 
embryological planes with sharp separation of the visceral 
and partial tissue layer (in analogy to the TME concept) 
and true central ligation of the supplying vasculature. The 
aim of CME is a greater extension of lymphadenectomy, 
a greater volume of intact mesentery and an adequate 
length of bowel resection, with the hypothesis that the 
oncological outcome would be improved by a more radical 
and targeted surgical approach. The first results reported 
were an increase in absolute survival to 89%, compared 
Fig. 7  Oncological outcomes: 
overall survival at 3 years
Fig. 8  Oncological outcomes: 
disease-free survival at 5 years
Table 5  Secondary outcomes
RR (relative risk) < 1 favours CME; > 1 favours non-CME. MD (mean difference) < 0 favours CME; > 0 favours non-CME
CME complete mesocolic excision
Number of stud-









RR/MD* 95% CI Hetero-
geneity 
(I2)%
Operative time 14 1736 902 834 16.43 4.27–28.60 95
Conversion from lapa-
roscopy to open right 
hemicolectomy
4 682 18/212 (8.49%) 35/460 (7.6%) 1.72 1.00–2.96 0
Intraoperative complica-
tions
3 365 19/178 (10.67%) 14/187 (7.48%) 1.14 0.60–2.15 0
Reoperation rate 4 591 7/299 (2.34%) 11/292 (3.76%) 0.65 0.26–1.75 0
Overall postoperative 
complications




3 447 19/155 (12.26%) 43/338 (11.92%) 1.36 0.82–2.28 0
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with 81% after traditional right hemicolectomy, with local 
recurrence of 3.5% compared to 6.5% [53].
At a time when laparoscopic surgery for colon cancer 
is largely standard clinical practice and validated from an 
oncological perspective [54], CME is a more complex and 
difficult intervention, requiring more operative experience 
and a longer learning curve [55]. The difficulty arises pri-
marily from the central ligation of the vessels supplying and 
draining the right colon. The vascularization of the right 
colon is extremely variable and the anatomical variations are 
mainly found at the level of the right colic artery and vein, 
the right branch of the middle colic artery and vein and in 
particular at the level of the venous branches of the trunk of 
Henle [56]. Since the oncological benefits of CME remain 
unclear and since laparoscopic CME is a technically difficult 
procedure to perform, CME has not yet become standard 
surgical treatment for right colon cancer.
It remains unclear whether these newer concepts of 
oncological radicality in colon cancer surgery need to be 
routinely considered, as has been the case for the appro-
priate use of TME in rectal cancer surgery. There is still 
uncertainty regarding the surgical treatment of right colon 
cancer. This is the basis for CME, which pursues the same 
oncological objective as D3 hemicolectomy, more common 
in Asia, or hemicolectomy with CVL [57].
Pending evidence on the oncological outcome of patients 
treated with CME compared with patients treated with tra-
ditional hemicolectomy for right colon cancer, the focus 
has largely been on short-term results and complications. 
The available literature is of variable quality with several 
retrospective, single-centre analyses providing comparisons 
between CME and traditional right hemicolectomy.
The strengths of our analysis include well-established 
guidance for conducting systematic reviews of observational 
and diagnostic data. We used standard pre-specified criteria 
for study assessment. We carefully avoided duplicate data. 
We performed a meta-analysis of the data, increasing sample 
size and precision compared to any single study. The identi-
fication of a single procedure, identified as right hemicolec-
tomy performed exclusively to treat malignant pathology 
by traditional surgical approach and CME, allowed further 
efforts to ensure a homogenous sample, reducing the risk of 
bias that would have arisen when comparing different surgi-
cal procedures. It should also be noted that in most of the 
studies analysed, the groups of CME patients and traditional 
surgery patients were well distributed, without substantial 
differences in age, body mass index and other possible con-
founding factors.
The limitations of our study include the difference in sam-
ple size in the analysed studies, many of which had small 
numbers of patients. Most of the analysed studies are ret-
rospective. We were able to include only three prospective 
studies. Only two studies had a sufficiently long follow-up 
to provide 5-year survival data. The variables analysed were 
often not homogeneously coded between the studies consid-
ered, and this reduced the number of comparable data points. 
An attempt at alignment of these data would have introduced 
possible bias. It was not always indicated whether any neo-
adjuvant chemotherapy was given prior to surgery, although 
this is not common practice. Some factors, such as the inci-
dence of complications, were not related to the extent of the 
tumour according to Union for International Cancer Control 
(UICC) staging in any of the studies analysed. Despite these 
differences in the analysis of the various studies, the sample 
of data obtained has a much higher magnitude than that of 
any single study, enhancing the results of our research.
This systematic review and meta-analysis is very different 
from the previous ones by Ow [58] and Wang [22] in that 
we only included patients with right colon cancer undergo-
ing right hemicolectomy, whereas in the other two meta-
analyses, all types of colic resection were included.
For this reason, the analyses of the other two studies pre-
sent a moderate heterogeneity (I2 = 60% in the analysis of 
5-year overall survival and I2 = 61% in the analysis of DFS). 
In our meta-analysis, only a few studies reported data on 
distant survival, so it was not possible to perform an analysis 
that would provide statistically significant data.
In fact, it has been demonstrated that right colon cancer 
has a different disease progression and has aa worse progno-
sis than left colon cancer which is related to a higher number 
of cases of advanced disease at diagnosis [59]. It must also 
be taken into account that the complication rate following 
standard right hemicolectomy is generally higher than that 
following left hemicolectomy [60].
Because of the cumulative analysis of patients with differ-
ent characteristics related to the site of colon cancer (right, 
transverse, and descending/sigma) and the multiplicity of 
surgical techniques performed the results of the two studies 
mentioned above were different from those of our study, in 
which the study population was homogeneous with regard 
to biology and surgical technique.
We divided the endpoints in our analysis into two mac-
rocategories: one concerning the feasibility and safety of 
CME compared to traditional right hemicolectomy; the other 
concerning the oncological outcome resulting from a more 
radical surgical approach.
The GRADE analysis yielded a very low grade of evi-
dence in all principal and oncological outcomes, with the 
exception of lymph node harvest in which the level of evi-
dence was low. For this reason, it is not possible to draw any 
conclusions of CME non-inferiority and better randomized 
clinical control trials are needed to support the non-inferi-
ority of CME.
As far as operating time is concerned, since the CME 
procedure is intrinsically more complex and detailed, it is 
to be expected that the duration of the operation is longer, 
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even in the absence of a standardised parameter for meas-
uring the actual operating room time. Although the trend 
shows a tendency for CME to take longer (only Lieto et al. 
[40] report shorter operating times for CME compared to 
standard hemicolectomy), this difference in our analysis was 
not statistically significant, and it is not associated with a 
greater incidence of intra- and postoperative complications, 
or longer hospital stay.
The conversion rate to open surgery in laparoscopic pro-
cedures was the only variable analysed that seems to favour 
the standard non-CME procedure, with a statistically sig-
nificantly lower conversion rate. It should be noted that only 
four studies, with small sample sizes, have reported these 
data. This may be partly due to the greater technical dif-
ficulty of the procedure, in addition to the variations of the 
vascular anatomy of the right colon. Another aspect to con-
sider is how a robotic approach may allow the procedure to 
be performed more readily than laparoscopy, and thus lead 
to a lower conversion rate. Early data seem to support this 
hypothesis, as the only robotic study we were able to evalu-
ate [48] did not report any conversions to open surgery, or 
any difference in rates of complications compared to the 
standard procedure.
In terms of oncological radicality, CME favours lymph 
node yield. This may suggest oncological superiority, but 
unfortunately, with the studies available in the literature to 
date, this cannot be effectively proven by evaluating and 
comparing the 3- and 5-year survival in a sufficiently large 
sample. It has been shown that greater surgical radicality 
may improve the chances of long-term survival [61], but 
further studies, possibly randomized and with longer follow-
up, are necessary to assess and quantify the real impact that 
this type of surgery has on the patient’s oncological out-
come. It should also be noted that our data show a higher 
heterogeneity in the lymph node yield during laparoscopic 
procedures if compared to open cases. This is probably due 
to the greater technical skill required to perform the proce-
dure with a minimally invasive approach [62].
Our data show that it is necessary to standardize the eval-
uation parameters regarding complications, their treatment 
modalities, and their time of onset after surgery; the record-
ing of operating time; and the standardization of parameters 
for evaluation of long-term survival, defining universal and 
easily comparable parameters, as other authors have sug-
gested [63]. A possible confounding factor derives from the 
fact that, since there is no universally accepted definition that 
standardizes the CME surgical procedure, it is not possible 
to be sure that the procedures performed in the different 
centres have followed the same precise steps. It is necessary 
to have a definition of quality easily applicable to the sur-
gical specimen obtained, outlined by univocal quantitative 
parameters, in order to be able to qualitatively analyse such 
a complex procedure.
We hope that in the near future the objective of the major 
surgical oncology and colorectal societies will be to plan and 
perform RCTs with a high level of methodological quality 
and adequate power analysis to clarify this important issue.
Conclusions
With the data available to date, it is not possible to defini-
tively demonstrate that CME has oncological superiority in 
terms of survival, but only that it has not proved inferior to 
traditional surgery in terms of feasibility and safety, and that 
it leads to an increased lymph node yield when compared 
with traditional right hemicolectomy. In the future, to iden-
tify its precise indications, its superiority will need to be 
proven in oncological terms, as has happened for TME in 
rectal cancer surgery. We are aware of five ongoing prospec-
tive studies that we will be eager to include in a future analy-
sis and anticipate that this will allow further light to be shed 
in defining the role of CME in surgery for right colon cancer.
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